Alzamend Neuro posts $3.03M quarterly net loss
For the quarter ended July 31, 2026, Alzamend Neuro reported a net loss of $3.03M and diluted net loss per share of $(0.68). The company recorded no product revenue.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.